IRIS
PRINCIPI, MARIABEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.417
AS - Asia 3.934
EU - Europa 3.282
SA - Sud America 1.109
Continente sconosciuto - Info sul continente non disponibili 715
AF - Africa 149
OC - Oceania 16
Totale 21.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.064
SG - Singapore 1.524
IT - Italia 1.125
CN - Cina 862
BR - Brasile 849
HK - Hong Kong 489
SE - Svezia 442
RU - Federazione Russa 437
VN - Vietnam 321
DE - Germania 317
GB - Regno Unito 224
FR - Francia 203
FI - Finlandia 164
BD - Bangladesh 149
CA - Canada 139
IN - India 116
UA - Ucraina 84
AR - Argentina 81
ID - Indonesia 71
IQ - Iraq 64
BE - Belgio 55
MX - Messico 53
TR - Turchia 48
ZA - Sudafrica 46
CO - Colombia 44
PL - Polonia 43
PK - Pakistan 39
EC - Ecuador 38
NL - Olanda 37
VE - Venezuela 33
ES - Italia 32
JP - Giappone 30
SA - Arabia Saudita 27
IL - Israele 26
UZ - Uzbekistan 26
GT - Guatemala 25
CL - Cile 22
RO - Romania 22
PH - Filippine 21
TT - Trinidad e Tobago 20
CR - Costa Rica 19
MA - Marocco 17
IE - Irlanda 16
NI - Nicaragua 16
CI - Costa d'Avorio 15
MY - Malesia 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
CW - ???statistics.table.value.countryCode.CW??? 14
HN - Honduras 14
PY - Paraguay 14
DZ - Algeria 13
EG - Egitto 13
SV - El Salvador 13
TN - Tunisia 13
AU - Australia 12
PE - Perù 12
PR - Porto Rico 12
AT - Austria 11
AZ - Azerbaigian 11
GP - Guadalupe 11
KE - Kenya 11
LT - Lituania 11
LB - Libano 9
TH - Thailandia 9
KR - Corea 8
KZ - Kazakistan 8
UY - Uruguay 8
BO - Bolivia 7
JM - Giamaica 7
NP - Nepal 7
BB - Barbados 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JO - Giordania 6
SC - Seychelles 6
EU - Europa 5
QA - Qatar 5
AG - Antigua e Barbuda 4
EE - Estonia 4
GR - Grecia 4
KG - Kirghizistan 4
MK - Macedonia 4
PA - Panama 4
PS - Palestinian Territory 4
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
FJ - Figi 2
IR - Iran 2
KW - Kuwait 2
MD - Moldavia 2
Totale 20.892
Salva come PNG Salva come JPEG
Città #
Fairfield 1.284
Ashburn 1.233
Woodbridge 918
Singapore 811
Chandler 680
San Jose 619
Houston 605
Seattle 512
Hong Kong 485
Cambridge 464
Wilmington 423
Ann Arbor 420
Nyköping 361
Milan 352
Beijing 295
Council Bluffs 266
Dallas 261
New York 240
Jacksonville 227
Los Angeles 154
Rome 136
Lawrence 133
Santa Clara 132
Roxbury 130
Nanjing 125
Lauterbourg 116
Ho Chi Minh City 105
Boardman 93
Bari 80
Des Moines 80
São Paulo 79
Helsinki 76
Princeton 71
Inglewood 69
Columbus 62
Brooklyn 58
Brussels 54
Hanoi 54
Dearborn 52
Chicago 50
Atlanta 49
San Diego 48
London 45
Buffalo 41
Jakarta 39
Warsaw 38
Munich 37
Phoenix 37
Turin 35
Frankfurt am Main 32
Montreal 32
Orem 31
Denver 29
The Dalles 29
San Francisco 28
Falkenstein 27
Figino 27
Shenyang 27
Toronto 27
Dong Ket 26
Jiaxing 26
Rio de Janeiro 26
Tianjin 25
Hebei 24
Nanchang 24
Tokyo 24
Paris 23
Guatemala City 22
Johannesburg 22
Tashkent 22
Baghdad 21
Mexico City 21
Naples 21
Changsha 20
Belo Horizonte 19
Bologna 19
Brasília 18
Dhaka 18
Haiphong 18
Moscow 18
Boston 17
Chennai 17
Curitiba 17
Dublin 17
Medellín 17
Nuremberg 17
Stockholm 17
Lahore 16
North Bergen 16
San José 16
Abidjan 15
Managua 15
Pune 15
Newark 14
Philadelphia 14
Willemstad 14
Ankara 13
Porto Alegre 13
Redwood City 13
Shanghai 13
Totale 13.786
Salva come PNG Salva come JPEG
Nome #
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 491
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 288
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 260
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 245
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 223
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 220
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 220
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 213
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 208
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 206
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 205
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 205
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 204
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 201
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 198
Estrogens, phytoestrogens and colorectal neoproliferative lesions 186
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 185
A mysterious case of gastroparesis: could the secret be found in a drink? 182
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 182
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 180
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 177
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 176
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 174
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 165
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 162
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 161
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 160
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 155
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 154
Celiac disease and common variable immunodeficiency: a familial inheritance? 154
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 153
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 153
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 153
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 151
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study 148
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 148
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 147
The cost of inflammatory bowel disease management matches with clinical course: A single outpatient centre analysis 147
The association between cardiac and gastrointestinal disorders: causal or casual link? 146
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 145
Oral Tacrolimus (FK-506) in Crohn' s disease complicated by fistulae of perineum 144
Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report. 144
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 144
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 141
The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy 139
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 136
La qualità della vita dei pazienti affetti da infiammazione intestinale 134
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 132
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 131
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 128
Seronegative celiac disease: where is the specific setting? 125
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 125
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 125
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 124
Pattern of apoptosis in Crohn’s disease: a singular aspect? 123
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 121
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 120
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 118
Effect of Helicobacter Pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression 116
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 113
La gastrite cronica da Helicobacter Heilmannii: una nuova entità istopatologica. L’ infezione da Helicobacter pilori: aggiornamento continuo G Bianchi Porro, G Maconi, F Parente 112
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 112
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 110
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data] 110
Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic 109
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 108
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. 107
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 105
Liver involvement in inflammatory bowel disease: What should the clinician know? 104
Appliance of immunohistochemical techniques in Helicobacter pylori infection. Immunohistochemistry and Helicobacter pylori 104
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 103
Probiotics and Helicobacter pylori 102
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 102
null 101
Differential immunohistochemical expression of Syndecan-1 and Tumor necrosis factor alpha in colonic mucosa of patients with Crohn’s disease 101
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 101
Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn disease: a case report 100
null 100
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 100
null 99
Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies 99
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 97
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 97
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 97
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 96
Prevalence and clinical significance of incidental extra-intestinal findings in MR enterography: experience of a single University Centre 96
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? 95
null 94
Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report. 94
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: A benefit in the long term? 93
Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease 93
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 92
Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation 91
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 91
Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study 90
null 90
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 90
Adalimumab and perianal Crohn's disease: Case report 90
null 89
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 89
Totale 14.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022810 0 0 0 0 54 101 27 55 61 90 166 256
2022/20231.688 241 235 124 140 154 239 23 184 261 12 47 28
2023/2024566 35 107 23 55 52 163 14 22 6 27 13 49
2024/20252.524 40 36 161 76 57 218 337 234 107 144 398 716
2025/20266.597 882 352 434 632 729 320 620 196 823 628 269 712
2026/20272.527 516 351 527 1.028 105 0 0 0 0 0 0 0
Totale 21.622